Table 1—

Baseline characteristics of study participants

Men
Women
Non-Hispanic whitesMexican AmericansNon-Hispanic whitesMexican Americans
n4228425061,171
Age (years)44 ± 1143 ± 1244 ± 1143 ± 11
BMI (kg/m2)27.1 ± 4.328.3 ± 4.625.5 ± 5.429.2 ± 6.5
Waist circumference (cm)96.2 ± 11.295.0 ± 11.581.9 ± 13.388.7 ± 15.5
Systolic blood pressure (mmHg)121.7 ± 13.5123.9 ± 14.2113.7 ± 15.5118.0 ± 16.5
Diastolic blood pressure (mmHg)73.9 ± 8.374.5 ± 9.269.0 ± 9.471.2 ± 8.9
Fasting glucose level (mmol/l)5.00 ± 1.145.37 ± 1.924.73 ± 0.935.40 ± 2.25
2-h glucose level (mmol/l)5.58 ± 2.626.96 ± 4.55.83 ± 2.527.82 ± 4.59
Total cholesterol level (mmol/l)5.08 ± 1.015.22 ± 1.195.04 ± 1.055.07 ± 1.04
HDL cholesterol level (mmol/l)1.09 ± 0.301.08 ± 0.311.38 ± 0.391.24 ± 0.33
Triglyceride level (mmol/l)1.42 ± 0.021.63 ± 0.021.08 ± 0.021.36 ± 0.02
Insulin level (mmol/l)8.84 ± 2.3611.2 ± 2.327.07 ± 2.5211.3 ± 2.35
IFG (≥5.6 and <7.0 mmol/l) (%)9.8 (7.2–13.1)11.5 (9.4–14.1)4.6 (3.0–6.9)7.4 (5.9–9.2)
Type 2 diabetes (%)5.0 (3.3–7.5)11.5 (9.5–13.9)4.0 (2.6–6.1)14.7 (12.8–16.9)
History of CVD (%)6.2 (4.2–8.9)9.7 (7.9–11.9)5.1 (3.5–7.4)7.4 (6.1–9.1)
ATPIII metabolic syndrome (%)24.0 (20.2–28.4)29.6 (26.6–32.8)16.8 (13.8–20.4)30.9 (28.3–33.6)
IDF metabolic syndrome (%)28.4 (24.2–32.9)40.4 (37.1–43.9)24.7 (21.1–28.7)38.5 (35.7–41.4)
WHO metabolic syndrome (%)18.8 (15.3–23.0)28.3 (25.2–31.7)12.1 (9.5–15.5)27.3 (24.7–30.1)
Cigarette smoking (%)29.6 (25.5–34.2)34.6 (31.4–37.8)23.7 (20.2–27.6)20.6 (18.4–23.0)
First-degree relative with diabetes (%)19.4 (15.8–23.5)36.5 (33.3–39.8)20.6 (17.3–24.4)43.4 (40.6–46.3)
First-degree relative with heart attack (%)35.0 (30.6–39.7)23.9 (21.2–26.9)35.3 (31.3–39.6)30.5 (27.9–33.2)
  • Data are n, means ± SD, or percent (95% CI).